(S,R,S)-AHPC-PEG2-N3

CAS No. 2010159-45-0

(S,R,S)-AHPC-PEG2-N3 ( VH032-PEG2-N3; VHL Ligand-Linker Conjugates 6; E3 ligase Ligand-Linker Conjugates 13 )

Catalog No. M26945 CAS No. 2010159-45-0

(S,R,S)-AHPC-PEG2-N3 is a synthesized E3 ligase ligand-linker conjugate containing a (S,R,S)-AHPC based VHL ligand and 2 unit PEG linker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 81 Get Quote
10MG 115 Get Quote
25MG 210 Get Quote
50MG 302 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (S,R,S)-AHPC-PEG2-N3
  • Note
    Research use only, not for human use.
  • Brief Description
    (S,R,S)-AHPC-PEG2-N3 is a synthesized E3 ligase ligand-linker conjugate containing a (S,R,S)-AHPC based VHL ligand and 2 unit PEG linker.
  • Description
    (S,R,S)-AHPC-PEG2-N3 is a synthesized E3 ligase ligand-linker conjugate containing a (S,R,S)-AHPC based VHL ligand and 2 unit PEG linker.
  • Synonyms
    VH032-PEG2-N3; VHL Ligand-Linker Conjugates 6; E3 ligase Ligand-Linker Conjugates 13
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2010159-45-0
  • Formula Weight
    601.7
  • Molecular Formula
    C28H39N7O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(N[C@@H](C(C)(C)C)C(N(C[C@H](O)C1)[C@@H]1C(NCC2=CC=C(C(SC=N3)=C3C)C=C2)=O)=O)COCCOCCN=[N+]=[N-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vega JA, et al. Effect of treatment with the dihydropyridine-type calcium antagonist darodipine (PY 108-068) on the expression of neurofilament protein immunoreactivity in the cerebellar cortex of aged rats. Mech Ageing Dev. 1994 Aug;75(2):169-77.
molnova catalog
related products
  • Araloside X

    Aralosides possess protective effect against experimental myocardial ischemia and infarction, the mechanism of myocardial protection may be attributed to the amelioration of FFA metabolic deterioration and membrane peroxidation induced by oxygen free radicals. Aralosides have anti-inflammatory effect, they also can effectively prevent acute alcoholic liver injury.

  • Obtusifoliol

    Obtusifoliol is a metabolic intermediate of sterols made by certain fungis, can be converted to Delta8,14-Sterol by enzyme ERG11 (CYP51F1).

  • Engeletin

    Engeletin possesses potent inhibition of PGE2 release with IC5 values of 19.6 μg/ml.